BioCentury
ARTICLE | Clinical News

VTP-34072: Phase II data

July 13, 2015 7:00 AM UTC

Top-line data from a double-blind, German Phase II trial in overweight Type II diabetics showed that once-daily oral VTP-34072 as an add-on to metformin background therapy missed Boehringer’s “predefi...